Login / Signup

Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with childhood systemic lupus erythematosus: a real-world interventional multi-centre study.

Ingrid Herta Rotstein GreinNatalia Ferreira PintoAline LoboNoortje GrootFlavio SztajnbokClovis Artur Almeida da SilvaLuciana B Paim MarquesSimone AppenzellerAline Garcia IslabãoClaudia Saad MagalhãesRozana Gasparello de AlmeidaBlanca BicaMelissa FragaAline Coelho Moreira da FragaMaria Carolina Dos SantosTeresa RobazziMaria Teresa Ra TerreriMarcia BandeiraHella PasmansRutger ScheppFiona van der KlisSytze de RoockNico WulffraatGecilmara Pileggi
Published in: Lupus (2020)
HPV vaccination in cSLE patients is safe and immunogenic. Since the seropositivity to HPV16 and HPV18 was higher for the three-dose schedule group, this regimen should be recommended for cSLE patients.
Keyphrases
  • end stage renal disease
  • systemic lupus erythematosus
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • high grade
  • peritoneal dialysis
  • rheumatoid arthritis
  • patient reported outcomes
  • young adults